Compounded Medications
BBB Accredited 2025
About Trim RX
Trim RX is a San Diego-based telehealth platform focused on compounded semaglutide and tirzepatide for medical weight loss. The operating company on file at the Better Business Bureau is MetaFit Pharma Solutions LLC, doing business as TrimRx, with headquarters at 12636 High Bluff Drive in San Diego. The platform is LegitScript-certified for both pharmacy and telemedicine — a meaningful third-party signal that the company maintains the operational and clinical standards LegitScript audits for. BBB accreditation was issued on June 18, 2025, though the profile is currently Not Rated due to active billing complaints.
Pricing follows a multi-month tiered structure that rewards longer commitments. Compounded semaglutide ranges from $349/month on a one-month plan down to $174/month on a 12-month plan, and compounded tirzepatide ranges from $449/month on a one-month plan down to $283/month on a 12-month plan. A current Winter Special applies $140 off the first month at checkout. Brand-name Wegovy, Ozempic, Mounjaro, and Zepbound are referenced as available options subject to availability and clinician evaluation, at full retail. Trim RX is cash-pay only — insurance is not billed — but HSA and FSA cards are accepted, and Buy-Now-Pay-Later financing is offered through Afterpay, Klarna, and AMEX Plan-It.
Where Trim RX earns its strongest grade is on clinical screening rigor. The intake captures the FDA black-box contraindications — including personal and family history for medullary thyroid cancer and MEN-2 syndrome — alongside a 22-item comorbidity multi-select that includes pancreatitis history, severe depression, sleep apnea, T1/T2 diabetes, retinopathy, warfarin use, fatty liver, congestive heart failure, and PCOS. Substance-use screening is handled directly: an opt-out exclusionary block flags current alcohol, opioid, or substance-use disorder, and a separate three-month opiate-history field requires free-text date range, name, dose, and frequency before the patient can advance. The flow also self-reports blood pressure range and resting heart rate, captures past GLP-1 use, and asks about prior bariatric surgery. The screening is genuinely thorough for a fast async provider.
Where Trim RX loses ground is on operational transparency. The website About page features a co-founder letter signed “Emily Parker and Jake Miller,” but the BBB filing for the operating LLC lists Gibran Suffy and Sergio Aguilera as the qualifying partners — an identity discrepancy our editorial team flags as a credibility concern. The year founded is not publicly disclosed. Compounding pharmacy partners are not publicly named — Trim RX markets “FDA-registered pharmacies” and references both 503A state-licensed compounders and 503B outsourcing facilities plus PCAB accreditation, but specific partners are not listed. Telehealth coverage is described as nationwide, but the only states explicitly advertised in detail are Florida, Georgia, North Carolina, and South Carolina. Lab testing is not included or bundled — patients are instructed to obtain labs through their primary care provider or a local lab.
Trustpilot data reflects this mixed picture. Across 727 reviews, Trim RX holds an overall 3.3 stars, with 57 percent five-star reviews alongside 29 percent one-star reviews — a polarized distribution where positive reviews praise responsive customer service and quick prescriptions and negative reviews concentrate on multi-month upfront billing surprises and cancellation friction. The published refund policy aligns with that complaint pattern: a three-month results guarantee exists but is gated by plan-adherence and monthly check-ins (and requires emailing guarantee@trimrx.com); standard refunds are otherwise only granted if a clinician disqualifies the patient at intake or for billing errors, and multi-month plans billed upfront are not refunded for unused months after cancellation. Patients who choose Trim RX should plan to commit deliberately and read the cancellation terms carefully before locking in a 6- or 12-month plan.
For the right patient — someone who values genuinely thorough clinical screening (including FDA black-box family history and substance/opioid screening), LegitScript dual-certification as a third-party operational signal, HSA/FSA acceptance, and tiered cash-pay pricing that drops below $200/month on long-term commitments — Trim RX is a serious option in the compounded GLP-1 category. For patients who weight verifiable ownership disclosure, named pharmacy partners, and refund flexibility above all else, the trade-offs are real and worth additional due diligence before locking in a multi-month plan.
At a Glance
Medications Offered
Compounded semaglutide, Compounded tirzepatide
Compounded — Subcutaneous Injection
Cost & Insurance
- Monthly: $174 – $449
- 6-month estimate: $1,044 – $2,694
- Insurance: No (cash-pay only)
- Self-pay: Yes (HSA / FSA accepted; Afterpay / Klarna / AMEX BNPL)
Clinical Features
- Lab testing: Not included (obtained via PCP or local lab)
- Dietitian access: 1-on-1 dietitian + journey + group coaching marketed (RD credentials not publicly disclosed)
- Verified Pharmacy: Not publicly disclosed (claims FDA-registered 503A/503B; PCAB accreditation)
- BBB Rating: Accredited 2025-06; Not Rated
Delivery & Access
- Format: Subcutaneous injection
- Nationwide telehealth: Claimed (FL/GA/NC/SC explicitly advertised)
- Speed: Fast (24-48 hour async provider review)
- Spanish-speaking providers: Not publicly disclosed
Trim RX GLP-1 Program
Start your GLP-1 weight loss journey with Trim RX today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Trim RX Intake Looks Like
We walked through the Trim RX intake ourselves — a 37-screen async flow across five clinical stages plus a separate checkout. The headline finding: clinical rigor is high, but the experience is padded with marketing interstitials and the multi-month plan billing model is loaded into the final checkout step. Here is what an actual prospective patient encounters.
Above average for the compounded category. The intake captures personal AND family history for medullary thyroid cancer and MEN-2, runs an opt-out exclusionary block on end-stage kidney/liver disease, suicidality, active cancer, organ transplant and severe GI disease, and includes a structured substance/opioid screen with a three-month opiate window requiring free-text date range, name, dose and frequency. Self-reported blood pressure and resting heart rate are collected. Knocked down by no validated PHQ-2/PHQ-9 instrument, no eating-disorder screen, no dedicated allergy screen, no ID/photo verification, and no phone OTP step.
Moderately high. Thirty-seven screens at roughly eleven minutes is long for the category, padded by three full-screen testimonial interstitials and a metabolic-science chart screen that adds no clinical input. The questionnaire is the substantive work; the marketing screens slow it. Account creation is deferred to the eligibility step (no email/password upfront) which mitigates early-funnel friction. Multi-month plan selection happens at checkout with the upfront-billing model surfaced clearly.
The 5 Clinical Stages
Clinical Safety Screens Performed
No validated PHQ-2 or PHQ-9 depression instrument — suicidality is captured as a binary exclusionary opt-out and “severe depression” is a checkbox on the comorbidity multi-select, but the validated brief screening scale is not used. No eating-disorder screen. No dedicated allergy screen — allergies are referenced indirectly through the current-medications free-text field rather than a structured panel. No ID or photo verification step for body composition or identity confirmation. No phone OTP step despite a phone number being collected at the eligibility stage. No detailed exercise history — diet and exercise willingness are collapsed into a single check-list. Sex is captured as Male / Female only.
After the eligibility step, the patient enters a two-step checkout. Step 1: Select Treatment — Compounded Semaglutide (“More Affordable”) or Compounded Tirzepatide (“Fastest Results, dual-action, but more expensive”). Step 2: Select Your Plan — Monthly ($399/mo with $140 OFF first month via the Winter Special), 3-Month ($256/mo, marked “Most Popular”), 6-Month ($253/mo, “saves $735”), and 12-Month (“Best Deal”). The 6-month tirzepatide plan is presented as a $1,519 total commitment with the WINTER140 promo applied. Multi-month plans are billed upfront — the dominant complaint pattern in published Trustpilot and BBB reviews concerns surprise upfront charges and cancellation friction on these tiers. The checkout includes HSA/FSA acceptance and Buy-Now-Pay-Later via Afterpay, Klarna and AMEX Plan-It, with a “$0 Due Today — only charged if your prescription is approved” reassurance.
A patient does not create a password or formal account before completing the clinical screening. Email and phone are captured at the eligibility step (with a HIPAA + Terms consent checkbox), and the formal account is created after checkout. That ordering keeps the clinical questionnaire reversible — a patient can abandon the flow before any payment information is captured, with only their email retained for follow-up marketing. The “Trim RX medical providers review every form within 24 hours” reassurance is shown explicitly at the end of the questionnaire.
Source: GLP-1.Reviews editorial walkthrough on May 1, 2026. We completed every screen of the Trim RX intake using a representative GLP-1 candidate persona and stopped before submitting a credit or debit card.
Opens trimrx.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
